Sitemap
Pages
- About
- Accessibility Statement
- Carbon Reduction Plan
- CCTA Advantage
- Clinical Evidence
- Clinical Research
- Contact Us
- DECIDE
- Elevate Decisive Coronary Care
- GameFilm
- Heartflow Analysis Intended Use
- Heartflow One
- Heartflow Privacy Policy
- Home
- Newsroom
- Patient Stories
- Plaque Calculator
- Reimbursement Resources
- SCCT.25
- Sitemap
- Terms of Use
- UK Modern Slavery Statement for 2025
- Understanding CAD
- Why Heartflow
Press Releases
- CMS Sets National Payment Rate for the Heartflow Analysis in Doctors’ Offices and Imaging Centers - 3 November 2021
- FFRCT RIPCORD Study: Availability of Heartflow FFRCT Analysis Changes the Management of Patients with Coronary Artery Disease - 19 May 2015
- Heartflow Achieves Landmark Milestone of 250,000 Patients Assessed for Coronary Artery Disease with FFRCT Analysis - 3 January 2024
- Heartflow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage - 3 June 2024
- Heartflow Analysis Demonstrates Highest Diagnostic Performance for Detecting Heart Disease Compared to Other Non-Invasive Tests - 22 May 2018
- Heartflow Analysis Enables Physicians to Confidently and Safely Differentiate Patients in Need of Invasive Treatment and Patients Who Can be Managed Medically for Coronary Artery Disease - 25 August 2018
- Heartflow Analysis is First AI-Enabled Technology to be Recognized by the American College of Cardiology and American Heart Association Guidelines as Important Tool in Diagnosing and Treating Heart Disease - 28 October 2021
- Heartflow and MedAxiom Announce Collaboration to Improve Care Delivery for Patients with Coronary Artery Disease - 5 May 2021
- Heartflow Announces CEO Transition - 1 March 2022
- Heartflow Announces Collaborative Research Agreement with Imperial College London - 7 March 2018
- Heartflow Announces Completion of Patient Enrollment in the PRECISE Trial - 11 May 2021
- Heartflow Announces Decision by Centers for Medicare & Medicaid Services to Assign a New Technology Payment Classification to Heartflow® FFRCT Analysis - 6 November 2017
- Heartflow Announces Enrollment of First Two Patients in REVEALPLAQUE Trial - 14 October 2021
- Heartflow Announces Favorable Coverage Determination for Plaque Analysis by Five Medicare Administrative Contractors - 24 October 2024
- Heartflow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions - 3 October 2022
- Heartflow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease - 18 October 2024
- Heartflow Announces New Commercial Coverage with UnitedHealthcare, Largest Health Insurer in U.S. - 27 June 2018
- Heartflow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access - 1 November 2024
- Heartflow Announces New Reimbursement Code and Increased Payment for FFRCT - 23 January 2024
- Heartflow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography - 12 March 2024
- Heartflow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients - 8 May 2024
- Heartflow Applauds Healthcare Stakeholders’ Push for Change in How Coronary Artery Disease is First Diagnosed - 29 October 2020
- Heartflow Appoints Cybersecurity Expert Julie Cullivan to its Board of Directors - 19 November 2020
- Heartflow Appoints Dr. Wayne J. Riley to its Board of Directors - 15 November 2021
- Heartflow Appoints Former Johnson & Johnson Chairman and CEO William C. Weldon to Board of Directors - 10 December 2014
- Heartflow Appoints John Farquhar as Chief Operating Officer - 4 August 2021
- Heartflow Appoints Timothy Barabe to its Board of Directors - 18 January 2022
- Heartflow Closes $98 Million Convertible Notes Financing - 26 March 2025
- Heartflow Enters into Licensing Agreement with Cedars-Sinai for Coronary Plaque Assessment Technology - 1 March 2018
- Heartflow FFRCT Analysis Receives Regulatory Approval in Japan - 17 November 2016
- Heartflow Files for FDA Clearance of Next Generation Product Offering to Help Evaluate the Presence of Narrowings and Plaque in the Coronary Arteries - 13 December 2021
- Heartflow Highlights Two Presentations at the 2020 American Heart Association Virtual Meeting - 10 November 2020
- Heartflow Initiates DECIDE Registry to Evaluate Utility of Heartflow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease - 26 March 2024
- Heartflow Initiates PRECISE Randomized Clinical Trial - 6 December 2018
- Heartflow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease - 18 July 2024
- Heartflow Introduces Next Generation Platform - 23 June 2016
- Heartflow Names Former J&J Chairman and CEO William C. Weldon Chairman of the Board - 21 June 2017
- Heartflow Plaque Analysis Awarded First Coverage Recommendation by Radiology Benefits Manager - 11 July 2025
- Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide - 22 July 2025
- Heartflow Receives 2011 EuroPCR Innovation Award - 20 May 2011
- Heartflow Receives FDA 510(k) Clearance for its Plaque Analysis and Roadmap™ Analysis - 18 October 2022
- Heartflow Receives National Reimbursement Approval in Japan - 14 November 2018
- Heartflow Secures 50th U.S. Patent - 7 October 2015
- Heartflow Secures De Novo Clearance from the U.S. Food and Drug Administration for Breakthrough FFRCT Technology - 1 December 2014
- Heartflow Survey: Fewer than 1/3 of Americans Know Biggest Health Threat - 7 February 2019
- Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - 27 August 2025
- Heartflow to Present Latest Data on AI-Enabled Coronary Artery Disease Management at TCT 2024 - 14 October 2024
- Heartflow to Showcase Landmark DECIDE Data at SCCT 2025, Advancing AI-Driven Care for Coronary Artery Disease - 30 June 2025
- Heartflow Unveils Bold New Vision for Management of Coronary Artery Disease - 25 February 2025
- Heartflow Unveils Landmark DECIDE Registry Data Demonstrating Impact of Heartflow Plaque Analysis on Coronary Artery Disease Medical Management - 17 July 2025
- Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares - 11 August 2025
- Heartflow, Inc. Announces Pricing of Upsized Initial Public Offering - 7 August 2025
- Heartflow, Inc. to Announce New Data on Diagnosing and Managing Coronary Artery Disease at the 2023 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting - 24 July 2023
- Heartflow, Leader in Revolutionizing Precision Heart Care, Closes $215 Million in Series F Funding Led by Bain Capital Life Sciences - 6 April 2023
- Heartflow’s Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study - 15 May 2024
- Landmark Study of Heartflow’s New Non-Invasive Diagnostic Test Demonstrates High Diagnostic Performance in Patients with Suspected Coronary Artery Disease - 30 October 2013
- Late-breaking Data Demonstrate AHA/ACC Guideline-directed CCTA + FFRCT Precision Pathway is Superior to Traditional Testing - 6 November 2022
- Late-Breaking Data Reinforces How the Heartflow Analysis Can Help Physicians Precisely Stratify Heart Disease Patients and Deliver More Personalized Care - 17 March 2019
- New 10-Year Data Demonstrate Superiority of the Heartflow Analysis in Predicting Long-Term Outcomes in Patients with Coronary Artery Disease - 18 May 2021
- New Analysis Published in Nature Medicine Demonstrates Advantages of Nationwide Coronary CTA Strategy with Heartflow FFRCT in Over 90,000 Patients with Coronary Artery Disease - 6 May 2025
- New Data from Clinical Studies Further Validate Heartflow’s All-in-One Portfolio of Precision Coronary Care Solutions - 28 July 2023
- New Data Highlight a Significant Increase in Cardiovascular Treatment Efficiency when the Heartflow Analysis is Incorporated into the Diagnostic Pathway - 16 October 2020
- New Heartflow Roadmap™ Analysis Now Available in U.S. to Assist CT Readers in Identifying Coronary Artery Narrowings - 17 April 2023
- New JACC Publication Reinforces Value of a Coronary CTA + Heartflow Analysis- Guided Pathway for Diagnosing Heart Disease - 15 January 2019
- New JAMA Network Open Publication Demonstrates the Coronary CT-Heartflow Analysis Pathway is ‘Dominant’ Compared to Stress Testing in Cost-Effectiveness Analysis - 14 December 2020
- New Medicare Local Coverage Determinations Published for the Heartflow Analysis - 6 April 2021
- NFL Alumni Joel Dreessen and Le-Lo Lang Team Up With Heartflow and Boone Heart Institute to Launch GAMEFILM Registry to Assess Heart Disease Risks in Retired Football Players - 22 January 2025
- NHS England and NHS Improvement mandate adoption of AI-powered Heartflow Analysis to fight coronary heart disease - 26 January 2021
- NHS England to Extend Reimbursement for the Heartflow Analysis through Innovation and Technology Payment (ITP) Program - 5 June 2019
- NHS England to Provide Innovation and Technology Payment (ITP) to Drive Adoption of Heartflow Analysis in the United Kingdom - 10 April 2018
- NHS Hospitals Turn to Deep Learning and Advanced Algorithms to Fight Heart Disease - 15 August 2018
- NICE Guidance Recommends Heartflow FFRCT Analysis to Help Determine Cause of Stable Chest Pain in Patients - 13 February 2017
- NICE Renews Support for Use of AI-powered Heartflow Analysis in Heart Disease Diagnosis - 26 April 2021
- One-Year PLATFORM Trial Results Reinforce Benefits of the Heartflow FFRCT Analysis for Assessing Coronary Artery Disease - 4 April 2016
- PLATFORM Trial Shows Heartflow FFRCT Analysis Significantly Decreases Unnecessary Invasive Diagnostic Testing for Coronary Artery Disease - 1 September 2015
- Positive Long-term Outcomes with Heartflow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024 - 27 October 2024
- Presented at SCCT – New Plaque Clinical Data Provides Additional Insights on Anatomy and Physiology in Clinical Decision Making for Patients - 21 July 2022
- Providence Health Care Becomes First Canadian Center to Adopt Revolutionary Heartflow FFRCT Analysis to Assess Coronary Artery Disease - 21 July 2016
- Recent Study from England’s National Health Service Highlights Positive Impact of Implementing Heartflow’s FFRCT Analysis for Diagnosis of Coronary Artery Disease - 26 August 2023
- SCCT 2024: Heartflow to Present New Data on Coronary Artery Disease Management with Coronary Computed Tomography Angiography - 16 July 2024
- TCT 2023: Heartflow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights - 25 October 2023
- Technology from Heartflow Provides Insights to Help Identify Coronary Plaques at Risk of Rupturing - 19 May 2016
- Trial Demonstrates Heartflow FFRCT Analysis Significantly Lowers Cost of Care, Improves Quality of Life for Coronary Artery Disease - 13 October 2015
- Use of Heartflow Planner Leads to Change in Treatment Strategy in Nearly Half of Patients with Coronary Heart Disease - 23 May 2019